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Abstract
Background:  Granulocyte colony-stimulating (G-CSF) factor is a well-known hematopoietic
growth factor stimulating the proliferation and differentiation of myeloid progenitors. Recently, we
uncovered that G-CSF acts also as a neuronal growth factor in the brain, which promotes adult
neural precursor differentiation and enhances regeneration of the brain after insults. In adults, the
receptor for G-CSF is predominantly expressed in neurons in many brain areas. We also described
expression in neurogenic regions of the adult brain, such as the subventricular zone and the
subgranular layer of the dentate gyrus. In addition, we found close co-localization of the G-CSF
receptor and its ligand G-CSF. Here we have conducted a systematic expression analysis of G-CSF
receptor and its ligand in the developing embryo.
Results: Outside the central nervous system (CNS) we found G-CSF receptor expression in blood
vessels, muscles and their respective precursors and neurons. The expression of the G-CSF
receptor in the developing CNS was most prominent in radial glia cells.
Conclusion: Our data imply that in addition to the function of G-CSF and its receptor in adult
neurogenesis, this system also has a role in embryonic neurogenesis and nervous system
development.
Background
Granulocyte colony-stimulating (G-CSF) factor is a
secreted glycoprotein of 20 kDa traditionally known as a
hematopoietic growth factor stimulating the proliferation
and differentiation of myeloid progenitors [1,2]. It is clin-
ically used for the treatment of chemotherapy-associated
neutropenia and for the mobilization of stem cells for
bone-marrow transplantations. In addition to this hemat-
opoietic function, we recently described important func-
tions in the central nervous system (CNS), including anti-
apoptotic properties on mature neurons, as well as a neu-
rogenic function in adult neural stem cells [3]. G-CSF and
its receptor are widely expressed in the adult CNS and
induced upon cerebral ischemia. Besides reducing infarct
volumes in stroke, G-CSF enhances long-term recovery
after insults to the brain, which is linked to an increase in
neurogenesis [3-5]. Taken together, these data underline
the clinical relevance of G-CSF as a potential new drug for
stroke and other neurodegenerative disorders (for review
see [6]).
G-CSF and its receptor show a broad, mainly neuronal,
colocalized expression throughout the murine brain [3].
Beside the expression in pyramidal neurons in the cortex
(mainly layers II/III and V), the Purkinje cell layer of the
cerebellum, the hippocampus (hilus and CA3 field), the
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entorhinal cortex and the olfactory bulb, G-CSF is also
expressed in neurogenic regions in the adult brain: in the
subgranular zone of the dentate gyrus and the subven-
tricular zone. To see whether the expression in the nerv-
ous system of the adult organism had any correlation to
embryonic expression of the receptor, we performed an
expression pattern study of the G-CSF receptor during
CNS development of the mouse embryo.
Results
G-CSF receptor expression outside the CNS throughout 
development of the rat embryo
In order to analyze the G-CSF receptor expression in the
murine embryonic development, we performed immuno-
histochemical stainings. Figure 1 gives examples of G-CSF
receptor expression outside the developing CNS from
E11–E19. G-CSF receptor expression can be found in ves-
sels of the cardiac ventricle (Figure 1A; E11), of the intes-
tine (Figure 1B, O; E12 and E19), of glomeruli in the
kidney (Figure 1C, M, N; E12 and E19) and in the wall of
blood vessels (Figure 1F; E16). Moreover, the G-CSF
receptor is expressed in neurons of the upper cervical dor-
sal root ganglia (Figure 1G, H; E16), in nerve fibers and
muscles of the tongue (Figure 1E, I, J; E12 and E16) and
in the developing retina (Figure 1L; E16). Receptor expres-
sion was also detected in muscle precursors (somite, Fig-
ure 1D; E12) and muscles (e.g. the external ocular muscles
in the eye (Figure 1K; E16). In addition, its expression can
be observed in the lens fibers of the eye (Figure 1L; E16).
Identification of mRNA expression of the G-CSF receptor 
and G-CSF in the developing CNS
Next we analyzed the G-CSF receptor expression in the
developing CNS. We detected expression of the G-CSF
receptor and G-CSF during murine embryonic CNS devel-
opment by reverse transcriptase PCR (RT-PCR). In heads
or brains of embryo development stages E11 – E18 and
postnatal day 2 (P2, Figure 2) PCR yielded the expected
product sizes (235 bp for G-CSF receptor and 360 bp for
G-CSF). G-CSF and its receptor are detected as early as
E11, and are expressed continuously throughout P2.
Immunohistochemical localization of the G-CSF receptor 
in the developing CNS
By immunohistochemistry, the RNA signal of the G-CSF
receptor at E11 corresponds to protein expression in the
telencephalic vesicle of the E11 embryo (Figure 3A). Later
in development we found G-CSF receptor expression in
other CNS regions, for example in the developing spinal
cord (Figure 3B, D, E; E12 and E16), in the hindbrain (Fig-
ure 3C, G; E16, E19), in the olfactory bulb (Figure 3H;
E19), in the diencephalon (Figure 3I; E21) and in the ret-
ina (Figure 1L, E16). Cells with G-CSF receptor expression
commonly displayed long and fine processes, which pass
through the neuroepithelial layer and terminate in small
end feets at the pial surface (e.g in Figure 3A). This mor-
phology matches exactly that described for radial glia cells
by Ramón y Cajal [7]. During postnatal development the
radial glia scaffold decreases and the G-CSF receptor is
expressed in developing neurons (Additional file 1).
In addition, we found G-CSF receptor expression in struc-
tures of the peripheral nervous system such as the dorsal
root ganglion and axon roots originating from the ventral
spinal cord (Figure 3B; E12).
G-CSF receptor and Nestin co-localize in the E16 rat 
embryo
To further prove that the structures which express the G-
CSF receptor in the developing nervous system are radial
glia cells, we performed co-immunofluorescence labeling
with the stem cell marker Nestin, which labels radial glia
cells at these embryonic stages (e.g. [8]). Figure 4 shows a
complete overlap of G-CSF receptor and Nestin signals in
cortex (Figure 4A–C), diencephalon (Figure 4D–F) and
spinal cord (Figure 4G–I) tissue.
Discussion
The embryonic expression pattern of the G-CSF receptor
can be divided into three main categories. The first cate-
gory with prominent G-CSF receptor expression consists
of blood vessels (e.g. the cardiac ventricles, in the intes-
tine, in the glomerular system of the kidney and in blood
vessels in the CNS (Figure 1A–C, 1F, 1M–O). Expression
in endothelial cells in the embryo is expected as the G-CSF
receptor is expressed in adult blood vessels, and G-CSF
has considerable effects on endothelial cell functions [9-
11]. Expression in blood vessels in the brain likely forms
the basis for blood-brain barrier penetration of G-CSF
[3,12], and for effects on G-CSF-induced vascular remod-
eling after stroke [13,14] or myocardial infarction [15].
The second category with G-CSF receptor expression is
formed by muscles and their progenitors (e.g. somites and
ocular muscle, Figure 1D, K).
Neurons represent the third category, where high abun-
dance of G-CSF receptor expression was observed in the
rat embryo (e. g. in the tongue, the upper cervical dorsal
root ganglia, Figure 1E, 1G–J). Broad neuronal expression
of G-CSF receptor and its ligand have been detected in the
adult CNS [3,16]. Using RT-PCR, we detected embryonic
expression of G-CSF receptor and G-CSF from E11 up to
postnatal day 2 in the brain, respectively head of mice,
consistent with the immunohistochemical detection. The
embryonic expression pattern of the G-CSF receptor in the
CNS is characterized by staining of elongated radial proc-
esses crossing through the developing neuroepithelium
(Figure 3) and terminating in conical endfeet at the the
pial surface (Figure 3A, G, I). We identified these cells asBMC Developmental Biology 2008, 8:32 http://www.biomedcentral.com/1471-213X/8/32
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The G-CSF receptor is expressed in structures outside the brain throughout development of the rat embryo Figure 1
The G-CSF receptor is expressed in structures outside the brain throughout development of the rat embryo. 
The figure gives an overview of the G-CSF receptor expression pattern in the rat embryo. A E11 heart, B E12 intestine, C E12 
kidney, D E12 somite, E E12 tongue, F E16 cerebral artery, G, H E16 cervical dorsal root ganglia, I, J E16 tongue, K, L E16 
eye, M, N E19 kidney, O E19 intestine, (Immunohistochemical staining of 10 μm paraffin sections, scale bar 50 μm, drg: dorsal 
root ganglia, E: embryonic day)
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radial glia because of their unique morphology and co-
expression of the intermediate filament protein Nestin
(initially described as monoclonal antibody Rat-401)
[17,18]. Because of their long processes, radial glia cells
were originally interpreted as a transient scaffold upon
which nascent neurons should migrate to their definitive
positions [19,20]. In recent years, the view of radial glia
cells as pure supportive cells has changed dramatically.
They are now regarded as multifunctional cells involved
in many aspects of brain and spinal cord development.
One important feature of radial glia might be the involve-
ment in CNS regionalization. In hindbrain development
for example, it has been shown that rhombomere bound-
aries are formed by radial glia cells in order to limit neu-
ronal migration [21]. Most intriguing however, is the
recent perception that radial glia cells are the neuronal
progenitors that generate neurons in the cerebral cortex
[22,23]. The remaining adult neural stem cells found for
example in the subventricular zone of the lateral ventricle
in the rodent forebrain are derived from the embryonic
radial glial population [24-26]. This strong relationship
between radial glia and adult stem cells is further high-
lighted by the fact that adult NSCs can redifferentiate to
radial glia [27]. The finding that the G-CSF receptor is
found on radial glial cells is therefore fully concordant
with our data on the later expression of the receptor on
adult neural stem cells [3,28].
Conclusion
Implications from our finding are threefold: First, it adds
a further dimension to the presence of the GCSF system in
the nervous system (i.e. embryonic expression and a likely
significance early in development of the nervous system).
Second, it underlines the link between radial glial cells
and adult neural stem cells where G-CSF has functional
relevance. Third, our data provide a new and highly spe-
cific marker (G-CSFR) for radial glial cells throughout cor-
tical neurogenesis.
Methods
Immunohistochemistry
Wistar rat embryos were fixed in 4% paraformaldehyde
and embedded in paraffin. 10 μm paraffin sections were
deparaffinized and microwaved in citrate buffer. For G-
CSF receptor staining sections were blocked in 1% H2O2
in TBS for 30 minutes at room temperature. After washing,
Expression of G-CSF and its receptor on the RNA level Figure 2
Expression of G-CSF and its receptor on the RNA level. G-CSF receptor (A) and its ligand G-CSF (B) are present 
throughout murine embryonic development, which is demonstrated by RT-PCR. RT-PCR products of the following stages 
were loaded on the gels: E11, E12, E14, E16, E18 and P2. As positive controls for G-CSF and G-CSF receptor sequence-verified 
cDNA clones were used. The negative control consisted of water. RNA was prepared out of E11 and E12 whole embryonic 
mouse heads, for the other stages mouse brain was taken. Primers are located in the 3' part of the open reading frames with 
product lengths of 235 bp for G-CSF receptor and 360 bp for G-CSF. (Pos., positive PCR control (G-CSF or G-CSF receptor, 
respectively; neg., negative control)
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incubation with the G-CSF receptor antibody (Santa Cruz
Biotechnology, Inc., sc-9173, 1:100) followed overnight
at 4°C in a humid chamber. Staining was visualized after
washing and secondary antibody incubation (anti-rabbit
biotin, Dianova) using the avidin-biotin complex (ABC)
technique with DAB as chromogen (DakoCytomation).
In order to visualize the nuclei, sections were treated with
haemalaun. The specifity of the G-CSF receptor staining is
demonstrated by omission of the primary antibody
(Additional file 2).
For double immunofluorescence with Nestin, the sections
were blocked in 0,2% BSA/TBS followed by antibody
incubation at 4°C overnight (anti-mouse nestin, Chemi-
con International, MAB353, 1:100) and G-CSF receptor
antibody. Subsequent washing, sections were incubated
for detection with the appropriate fluorescent dye-conju-
G-CSF receptor is expressed in the embryonicnervous system Figure 3
G-CSF receptor is expressed in the embryonic nervous system. The expression shows characteristics of radial glia 
cells in terms of long processes and termination in end-feet. A E11 forebrain, B E12 spinal cord with dorsal root ganglion, axon 
root and muscle, C E14 hindbrain, D E16 spinal cord with dorsal root ganglion, E E19 spinal cord, F E19 spinal cord, G E19 
hindbrain, H E21 olfactory bulb, I E21 diencephalon, (Immunohistochemical staining of 10 μm paraffin sections, scale bar = 50 
μm, d: dorsal, E: embryonic day, v: ventral).
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gated secondary antibodies (anti-mouse FITC and anti-
rabbit Cy5, Dianova, 1:200). Nuclear staining was per-
formed using Hoechst33342.
RT-PCR
RNA of mouse brains (E14, 16, 18, P2) and mouse heads
(E11, 12) respectively was isolated using phenol-chloro-
form extraction [29] followed by QIAGEN RNeasy Mini
Kit purification according to the manufacturer's recom-
mendations. cDNA was synthesized from 5 μg total RNA
using oligo-dT primers and Superscript III Reverse Tran-
scriptase (Invitrogen Corp.). The following primers were
used for RT-PCR: mouse G-CSF-790s, GGA GCT CTA AGC
TTC TAG ATC; mouse G-CSF-1154as, TAG GGA CTT CGT
TCC TGT GAG; mouse G-CSF receptor-2582s, TGT GCC
CCA ACC TCC AAA CCA; mouse G-CSF receptor-2817as,
GCT AGG GGC CAG AGA CAG AGA CAC. Cycling condi-
tions were as follows for G-CSFR: 5 minutes at 95°C, 30
seconds at 95°C, 30 seconds at 60°C, 30 seconds at 72°C
for 34 cycles. The final extension time was 7 minutes at
72°C. For G-CSF, the same program was used after 2
cycles of a touchdown program from 64°C–62°C.
G-CSF receptor and Nestin co-localize in the nervous system of the E16 rat embryo Figure 4
G-CSF receptor and Nestin co-localize in the nervous system of the E16 rat embryo. The G-CSF receptor staining 
is shown in red, the signal for Nestin green. On images A-C the staining was performed on cortex tissue, D-F diencephalon 
and G-I spinal cord tissue. C, F and I are merged images.(Immunofluorescent staining on 10 μm paraffin sections, scale bar 50 
μm, E: embryonic day).
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Additional file 1
During postnatal development the radial glia scaffold decreases and 
the G-CSF receptor is expressed in emerging neurons. The figure shows 
a G-CSF receptor immunostaining at postnatal day 7. The decreasing 
radial glia scaffold is marked by arrows. (10 μm paraffin sections, scale 
bar 50 μm)
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-32-S1.pdf]
Additional file 2
Control for G-CSF receptor immunostaining specificity. The figure 
demonstrates a control for staining specificity of the G-CSF receptor by 
omission of the primary antibody. A, E17, spinal cord, G-CSF receptor 
immunostaining, B, control with omission of the primary antibody. 
(Immunofluorescent staining on 10 μm paraffin sections, scale bar 50 
μm, E: embryonic day).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-32-S2.pdf]